+#+TITLE: Laboratory Methods for Quantitative Acylcarnitines in Biological Matrices
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

* Introduction
- Carnitine (\beta{}-hydroxy-\gamma{}-N-trimethylaminobutyric acid) is
  an endogenous quaternary ammonium compound synthesized from lysine
  and methionine.
- L-Carnitine has been described as a "conditionally essential"
  nutrient for humans.
- Populations with an exogenous carnitine requirement include:
  - infants (premature and full-term),
  - patients on long-term parenteral nutrition,
  - perhaps children.
- Exogenous carnitine is required to maintain "normal" (in the
  epidemiologic sense) plasma or serum carnitine concentrations in
  humans of all ages.
- Primary function is to shuttle long chain fatty acids to the
  mitochondrial matrix, for \beta{}-oxidation.
- Acylcarnitines are markers for FAODs and OAs

\vspace{2em}

#+BEGIN_LaTeX
\centering
\chemname{\chemfig[][scale=.5]{H3C-N^{+}([2]-CH3)([6]-CH3)-CH2-C([2]-H)([6]-OH)-CH_2-C([1]=O)([7]-O^{-})}}{\tiny Carnitine}
\hspace{3em}
\chemname{\chemfig[][scale=.5]{H3C-N^{+}([2]-CH3)([6]-CH3)-CH2-C([2]-H)([6]-O-C([0]=O)-{\color{red}R})-CH_2-C([1]=O)([7]-O^{-})}}{\tiny Acylcarnitine}
%\chemname{\chemfig[][scale=.5]{H3C-N^{+}([2]-CH3)([6]-CH3)-CH2-C([2]-H)([6]-O-C([0]=O)-{\color{red}R})-CH_2-C([2]=O)-O-CH_2-CH_2-CH_2-CH_3}}{\tiny Acylcarnitine, butyl ester}
#+END_LaTeX


* Diagnostic FIA-MS/MS
** Diagnostic FIA-MS/MS schematic
#+BEGIN_LaTeX
\begin{center}
\begin{tikzpicture}[node distance=7em]
% nodes
\node(ms1)[ms]{MS1: Mass Filter};
\node(cc)[ms, right of=ms1]{Collision cell};
\node(ms2)[ms, right of=cc]{MS2: Mass Filter};
\node(ion)[ms, below of=ms1,yshift=3em]{Ionization};
\node(lc)[msw, below of=ion,yshift=3em]{Fused silica};
\node(detector)[ms, below of=ms2, yshift=3em]{Detector};
% arrows
\draw[arrow](lc) -- (ion);
\draw[arrow](ion) -- (ms1);
\draw[arrow](ms1) -- (cc);
\draw[arrow](cc) -- (ms2);
\draw[arrow](ms2) -- (detector);
\end{tikzpicture}
\end{center}
#+END_LaTeX
- ESI in positive mode
** Inlet table                                                     :noexport:

#+tblname: data-table
| Time |  Flow |  %A | %B |
|------+-------+-----+----|
|    0 |  1.00 | 100 |  0 |
|  0.3 | 0.095 | 100 |  0 |
|  1.2 | 0.100 | 100 |  0 |
| 1.55 | 0.500 | 100 |  0 |
| 1.85 | 0.100 | 100 |  0 |
|  2.5 | 0.100 | 100 |  0 |

** Sample prep
- Sample Type
  - Plasma
    - Diagnostic testing for FAODs and OAs
    - Monitoring
  - Urine
    - Diagnosis of CUD
- 20 \micro{}L of sample is mixed with 400 \micro{}L of IS in Methanol centrifuge to deproteinize.
- supernatant is removed and 100 \micro{}L of n-butanol-3M HCL is added
- dried down
- reconstituted with 200 \micro{}L 80% acetonitrile.
- 7.5 \micro{}L injection.

#+begin_src gnuplot :var data=data-table :file ./ac/figures/outletmethod.pdf
reset
set title "UPLC Method"
set key on
set xlabel "min"

set xrange [0:3]

set ylabel "ml/min"
set yrange [0:1.2]

plot data u 1:2 w lp lw 2 t "80% ACN"

#+end_src

#+ATTR_LATEX: :width 0.7\textwidth
#+RESULTS:
[[file:./ac/figures/outletmethod.pdf]]

** Fragmentation
#+BEGIN_LaTeX
\definesubmol{x}{-[1,.6]-[7,.6]}
\centering
 \chemname{\chemfig[][scale=.33]{H_{3}C-N^{+}([2]-CH_3)([6]-CH_{3})-CH_2-C([2]-H)([6]-O-C([0]=O)-{\color{red}R})-CH_2-C([2]=O)-O-CH_2-CH_2-CH_2-CH_3}}{\tiny acylcarnitine, butyl ester}

\vspace{2.5em}

 \chemname{\chemfig[][scale=.33]{H_{3}C-N([1]-CH_3)([7]-CH_3)}}{\tiny trimethylamine}
\hspace{2em}
\chemname{\chemfig[][scale=.33]{{\color{red}R}-C([1]=O)([7]-OH)}}{\tiny carboxylic acid}
\hspace{2em}
 \chemname{\chemfig[][scale=.33]{H!x!x}}{\tiny butyl group}
\hspace{2em}
 \chemname{\chemfig[][scale=.33]{H_{2}C^{+}-HC=CH-C([1]=O)([7]-OH)}}{\tiny 85 m/z}
#+END_LaTeX
** Precursor Ion Scan
#+BEGIN_LaTeX
\begin{center}
\begin{tikzpicture}
\node[box](ms1)[]{};
\node[label](ms1u)[above=of ms1,yshift=-3em]{MS1};
\node[label](ms1l)[below=of ms1,yshift=3em]{scanning};
\node[box](cc)[right= of ms1]{};
\node[label](ccu)[above=of cc,yshift=-3em]{Collision cell};
\node[label](ccl)[below=of cc,yshift=3em]{fragmentation};
\node[box](ms2)[right= of cc]{};
\node[label](ms2u)[above=of ms2,yshift=-3em]{MS2};
\node[label](ms2l)[below=of ms2,yshift=3em]{85 m/z};
\draw[->](ms1) -- (cc);
\draw[->](cc) -- (ms2);

%ms1
\draw [gray,->, decorate,decoration=snake] (-.8,0.5) -- (.8,0.5);
\draw [gray,->, decorate,decoration=snake] (-.8,0.25) -- (.8,0.25);
\draw [blue, ->,decorate,decoration=snake] (-.8, 0) -- (.8,0);
\draw [gray,->, decorate,decoration=snake] (-.8,-0.25) -- (.8,-0.25);
\draw [gray,->,decorate,decoration=snake] (-.8,-0.5) -- (.8,-0.5);

%cc
\draw [blue,->,decorate,decoration=snake] (2.1, 0) -- (2.4,0);
\fill (2.6,0) circle (0.1); 
\draw [gray,->,decorate,decoration=snake] (2.8, 0) -- (3.8,0.5);
\draw [red, ->,decorate,decoration=snake] (2.8, 0) -- (3.8,0);
\draw [gray,->,decorate,decoration=snake] (2.8, 0) -- (3.8,-0.5);

%ms2
\draw [red,->,decorate,decoration=snake] (5.1, 0) -- (6.8,0);
\end{tikzpicture}
\end{center}
#+END_LaTeX

** MRM is used to detected dicarboxylic acylcarnitines

- C0-Bu 218.1 Da \to 103 Da transition is optimal
- All others benefit from the added sensitivity of MRM mode as compared to parent ion scan

#+CAPTION[]:MRM is used to detected selected acylcarnitines
#+NAME: tab:mrnac
| Compound | Reaction        |
|----------+-----------------|
| C0       | 218.10 > 103.00 |
| C0 IS    | 227.10 > 103.00 |
| C2       | 260.20 > 85.00  |
| C2 IS    | 263.20 > 85.00  |
| C3       | 274.20 > 85.00  |
| C3 IS    | 277.20 > 85.00  |
| C3DC     | 360.30 > 85.00  |
| C4DC     | 374.30 > 85.00  |
| C5DC     | 388.35 > 85.00  |
| C5DC IS  | 391.35 > 85.00  |
| C6DC     | 402.45 > 85.00  |
| C8DC     | 430.45 > 85.00  |

#+CAPTION[]: Quantified Acylcarnitines
#+NAME: tab:ac
| C0    | C8     | C16      |
| C2    | C8:1   | C16:1    |
| C3    | C10    | C16:1-OH |
| C3DC  | C10:1  | C16-OH   |
| C4    | C12    | C18      |
| C4DC  | C12:1  | C18:1    |
| C5    | C14    | C18:1-OH |
| C5:1  | C14:1  | C18:2    |
| C5DC  | C14:2  | C18-OH   |
| C5-OH | C14-OH |          |
| C6    |        |          |
| C6DC  |        |          |

** Overestimation of Free Carnitine

- Butylated acylcarnitines are converted to butylated carnitine in
  n-butanol-3M HCl at 65\degree{}C. [fn:johnson]

| Acyl Carnitine | Half-life (min) |
|----------------+-----------------|
| C2             |              31 |
| C10            |             125 |
| C18            |             172 |

- 65\degree{}C for 15 min.  
- NSO uses 60\degree{}C for 20 minutes.
- IMD uses 55\degree{}C for 20 minutes.

- In a sample with low free carnitine and high acetylcarnitine.
  - 30% of the acetylcarnitine and smaller amounts of higher
    molecular mass acylcarnitines are converted to carnitine
  - a low carnitine sample could appear to be normal.
- "The free carnitine results obtained by this screening method on
  blood spots with high levels of acylcarnitines should therefore be
  used with caution." [fn:johnson]

[fn:johnson] Johnson, D. W. (1999). Inaccurate measurement of free
carnitine by the electrospray tandem mass spectrometry screening
method for blood spots. Journal of Inherited Metabolic Disease, 22(2),
201â€“202. 

** Pros and Cons of Butanol  FIA-MSMS for Aceylcarnitines
*** Pros
- Speed
- Sensitivity
- Expertise
- Amino acid measurement
*** Cons
- Isobaric compounds
  - C5DC and C10-OH
- Overestimation of CO due to hydrolysis


* TODO Free and Total Carnitine
- Method?
** Fractional Tubular Re-absorption of Carnitine

#+BEGIN_LaTeX
\begin{equation*}
FTR_{carnitine}\% = \left( 1 -  \frac{carnitine_{urine} \cdot creatinine_{plasma}}{carnitine_{plasma} \cdot creatinine_{urine}}\right) \cdot 100
\end{equation*}
#+END_LaTeX

- normally >98%, \Downarrow in CUD

** Free/Total Carnitine

\[
\frac{Free_{carnitine}}{Total_{carnitine}} = \frac{C_0}{\sum_{0}^{18} C_n}
\]

- \Downarrow in CUD, < 5-10% of normal 
